Clinical Trial Update: Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 study evaluating tasquinimod in primary myelofibrosis and myelofibrosis following PV or essential thrombocythemia is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• Tasquinimod (tasquinimod)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Phase 1, Phase 2 | Status: RECRUITING